Drug retention, inactive disease and response rates in 1860 patients with axial spondyloarthritis initiating secukinumab treatment : routine care data from 13 registries in the EuroSpA collaboration

© Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.

Detalhes bibliográficos
Autor principal: Michelsen, Brigitte (author)
Outros Autores: Lindström, Ulf (author), Codreanu, Catalin (author), Ciurea, Adrian (author), Zavada, Jakub (author), Loft, Anne Gitte (author), Pombo-Suarez, Manuel (author), Onen, Fatos (author), Kvien, Tore K. (author), Rotar, Ziga (author), Santos, Maria (author), Iannone, Florenzo (author), Hokkanen, Anna-Mari (author), Gudbjornsson, Bjorn (author), Askling, Johan (author), Ionescu, Ruxandra (author), Nissen, Michael J. (author), Pavelka, Karel (author), Sanchez-Piedra, Carlos (author), Akar, Servet (author), Sexton, Joseph (author), Tomsic, Matija (author), Santos, Helena (author), Sebastiani, Marco (author), Österlund, Jenny (author), Geirsson, Arni Jon (author), Macfarlane, Gary (author), van der Horst-Bruinsma, Irene (author), Georgiadis, Stylianos (author), Brahe, Cecilie Heegaard (author), Ørnbjerg, Lykke Midtbøll (author), Hetland, Merete Lund (author), Østergaard, Mikkel (author)
Formato: article
Idioma:eng
Publicado em: 2021
Assuntos:
DMARDs (biologic)
Outcomes research
Spondyloarthritis
Texto completo:http://hdl.handle.net/10451/46293
País:Portugal
Oai:oai:repositorio.ul.pt:10451/46293
Descrição
Resumo:© Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.

Registros relacionados